Elanco Animal Health Inc
ELAN22.305USD
+0.215+0.97%
終値 12/19, 16:00（ET）15分遅れの株価
11.08B時価総額
308.38直近12ヶ月PER
詳細情報 Elanco Animal Health Inc 企業名
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Incの企業情報
企業コードELAN
会社名Elanco Animal Health Inc
上場日Sep 20, 2018
最高経営責任者「CEO」Simmons (Jeffrey N)
従業員数9000
証券種類Ordinary Share
決算期末Sep 20
本社所在地450 Elanco Circle
都市INDIANAPOLIS
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号46221
電話番号18773526261
ウェブサイトhttps://www.elanco.com/
企業コードELAN
上場日Sep 20, 2018
最高経営責任者「CEO」Simmons (Jeffrey N)
Elanco Animal Health Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
160.34K
+6.87%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
+10.39%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
+12.74%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
+12.99%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
84.81K
+13.84%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1.82%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+100.82%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
160.34K
+6.87%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
+10.39%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
+12.74%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
+12.99%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Pet Health
643.00M
51.81%
Farm Animal
583.00M
46.98%
Contract Manufacturing
15.00M
1.21%
地域別USD
会社名
収益
比率
International
648.00M
52.22%
United States
593.00M
47.78%
事業別
地域別
事業別USD
会社名
収益
比率
Pet Health
643.00M
51.81%
Farm Animal
583.00M
46.98%
Contract Manufacturing
15.00M
1.21%
株主
更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Dodge & Cox
16.66%
Fidelity Management & Research Company LLC
10.21%
PRIMECAP Management Company
10.05%
The Vanguard Group, Inc.
9.75%
BlackRock Institutional Trust Company, N.A.
8.13%
他の
45.19%
株主統計
株主統計
比率
Dodge & Cox
16.66%
Fidelity Management & Research Company LLC
10.21%
PRIMECAP Management Company
10.05%
The Vanguard Group, Inc.
9.75%
BlackRock Institutional Trust Company, N.A.
8.13%
他の
45.19%
種類
株主統計
比率
Investment Advisor
70.39%
Investment Advisor/Hedge Fund
36.66%
Hedge Fund
5.79%
Research Firm
1.90%
Individual Investor
1.13%
Pension Fund
1.08%
Bank and Trust
0.65%
Sovereign Wealth Fund
0.18%
Family Office
0.11%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
852
577.24M
120.43%
+30.91K
2025Q3
891
577.57M
121.95%
+32.95M
2025Q2
878
543.55M
113.98%
+36.20M
2025Q1
945
503.90M
116.31%
-73.53M
2024Q4
964
498.16M
117.36%
+7.74M
2024Q3
970
490.73M
118.81%
+19.54K
2024Q2
1004
491.01M
118.24%
+1.27M
2024Q1
1021
489.85M
119.72%
-100.34M
2023Q4
1018
489.74M
120.73%
-3.72M
2023Q3
1027
490.57M
119.00%
+3.49M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Dodge & Cox
82.90M
16.69%
-25.35K
-0.03%
Jun 30, 2025
Fidelity Management & Research Company LLC
48.24M
9.71%
+9.93M
+25.93%
Jun 30, 2025
PRIMECAP Management Company
51.77M
10.42%
+1.54M
+3.07%
Jun 30, 2025
The Vanguard Group, Inc.
47.65M
9.59%
-496.16K
-1.03%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
19.58M
3.94%
-484.75K
-2.42%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
19.55M
3.94%
+3.57M
+22.35%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
22.75M
4.58%
+2.28M
+11.15%
Jun 30, 2025
UBS Financial Services, Inc.
10.31M
2.08%
+5.99M
+138.56%
Jun 30, 2025
State Street Investment Management (US)
9.13M
1.84%
-125.36K
-1.35%
Jun 30, 2025
Fidelity Institutional Asset Management
16.64M
3.35%
+1.09M
+7.01%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares U.S. Pharmaceuticals ETF
4.06%
Adaptiv Select ETF
3.38%
State Street SPDR S&P Pharmaceuticals ETF
3.15%
Brandes US Small-Mid Cap Value ETF
3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.84%
VanEck Agribusiness ETF
2.3%
First Trust Health Care Alphadex Fund
1.92%
Federated Hermes MDT Large Cap Value ETF
1.9%
First Trust NASDAQ Pharmaceuticals ETF
1.33%
Invesco S&P MidCap 400 Pure Value ETF
1.22%
詳細を見る
iShares U.S. Pharmaceuticals ETF
比率4.06%
Adaptiv Select ETF
比率3.38%
State Street SPDR S&P Pharmaceuticals ETF
比率3.15%
Brandes US Small-Mid Cap Value ETF
比率3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率2.84%
VanEck Agribusiness ETF
比率2.3%
First Trust Health Care Alphadex Fund
比率1.92%
Federated Hermes MDT Large Cap Value ETF
比率1.9%
First Trust NASDAQ Pharmaceuticals ETF
比率1.33%
Invesco S&P MidCap 400 Pure Value ETF
比率1.22%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Elanco Animal Health Incの上位5名の株主は誰ですか？
Elanco Animal Health Incの上位5名の株主は以下のとおりです。
Dodge & Coxは82.90M株を保有しており、これは全体の16.69%に相当します。
Fidelity Management & Research Company LLCは48.24M株を保有しており、これは全体の9.71%に相当します。
PRIMECAP Management Companyは51.77M株を保有しており、これは全体の10.42%に相当します。
The Vanguard Group, Inc.は47.65M株を保有しており、これは全体の9.59%に相当します。
BlackRock Institutional Trust Company, N.A.は19.58M株を保有しており、これは全体の3.94%に相当します。
Dodge & Coxは82.90M株を保有しており、これは全体の16.69%に相当します。
Fidelity Management & Research Company LLCは48.24M株を保有しており、これは全体の9.71%に相当します。
PRIMECAP Management Companyは51.77M株を保有しており、これは全体の10.42%に相当します。
The Vanguard Group, Inc.は47.65M株を保有しており、これは全体の9.59%に相当します。
BlackRock Institutional Trust Company, N.A.は19.58M株を保有しており、これは全体の3.94%に相当します。
Elanco Animal Health Incの株主タイプ上位3種は何ですか？
Elanco Animal Health Incの株主タイプ上位3種は、
Dodge & Cox
Fidelity Management & Research Company LLC
PRIMECAP Management Company
Dodge & Cox
Fidelity Management & Research Company LLC
PRIMECAP Management Company
Elanco Animal Health Inc（ELAN）の株式を保有している機関の数はいくつですか？
2025Q4時点で、Elanco Animal Health Incの株式を保有している機関は852社あり、保有株式の総市場価値は約577.24Mで、全体の120.43%を占めています。2025Q3と比較して、機関の持ち株は-1.52%増加しています。
Elanco Animal Health Incの最大の収益源は何ですか？
FY2025Q2において、Pet Health部門がElanco Animal Health Incにとって最大の収益を生み出しており、その金額は643.00Mで、全収益の51.81%を占めています。
